References: Approach to acute arrhythmia management in atrial fibrillation

  • Capucci A, Lenzi T, Boriani G, Trisolino G, Binetti N, Cavazza M, et al. Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension. Am J Cardiol 1992;70(1):69-72. https://www.ncbi.nlm.nih.gov/pubmed/1615873
  • January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC, Jr., et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 2019;140(2):e125-e51. https://www.ncbi.nlm.nih.gov/pubmed/30686041
  • Jordaens L, Trouerbach J, Calle P, Tavernier R, Derycke E, Vertongen P, et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J 1997;18(4):643-8. https://www.ncbi.nlm.nih.gov/pubmed/9129896
  • Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 2020;383(14):1305-16. https://www.ncbi.nlm.nih.gov/pubmed/32865375
  • National Institute for Health and Care Excellence (NICE). Atrial fibrillation: diagnosis and management [ng196]. London: NICE; 2021. https://www.nice.org.uk/guidance/ng196
  • NHFA CSANZ Atrial fibrillation guideline working group, Brieger D, Amerena J, Attia J, Bajorek B, Chan KH, et al. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: Australian clinical guidelines for the diagnosis and management of atrial fibrillation 2018. Heart Lung Circ 2018;27(10):1209-66. https://www.ncbi.nlm.nih.gov/pubmed/30077228